Casemix and CMI data are more than technical tools for claims management. They are essential for understanding case complexity, evaluating tariffs, strengthening HTA, improving referral control, and ensuring fairer health financing within Indonesia’s JKN system.
Incomplete casemix and CMI data can weaken evidence-based advocacy, tariff evaluation, HTA, and equitable health financing. This infographic summarises key JKN 2024 pressures, data limitations, policy impacts, and strategic solutions.